Clinical manifestations and risk factors of shock in children with multisystem inflammatory syndrome

Wu, Chi-HsienChi-HsienWuChang, Tu-HsuanTu-HsuanChangTan, Boon-FattBoon-FattTanJHONG-LIN WUHuang, Song-MingSong-MingHuangTING-YU YENEN-TING WUMING-TAI LINCHING-CHIA WANGCHUN-YI LULUAN-YIN CHANGLI-MIN HUANG2024-01-102024-01-102024-04-010929-6646https://scholars.lib.ntu.edu.tw/handle/123456789/638383Multisystem inflammatory syndrome in children (MIS-C) is a novel disease associated with COVID-19. The COVID-19 epidemic peaked in May 2022 in Taiwan, and we encountered our first case of MIS-C in late May 2022. We aimed to present patients' clinical manifestations and identify risk factors for shock.enCOVID-19; MIS-C; Procalcitonin; Risk factor; Shock[SDGs]SDG3Clinical manifestations and risk factors of shock in children with multisystem inflammatory syndromejournal article10.1016/j.jfma.2023.10.002379036932-s2.0-85175327269https://api.elsevier.com/content/abstract/scopus_id/85175327269